Home > Technical section > Biotechnology > Biotech companies > Molecular Profiling Institute
Molecular Profiling Institute
Monday 10 December 2007
MPI is a reference lab that offers prognostic testing services and genomic and proteomic profiling for cancer and other complex diseases.
Its proprietary offerings include Target Now, a late-stage cancer panel; Mammostrat, an early-stage breast cancer test; and CardioEvaluatR, which is a cardiovascular disease management panel.
MPI also has a Tissue Banking and Analysis Center offering biospecimen procurement, tracking, storage, analysis, and reporting for diagnostics and pharmaceutical companies and medical centers.
News
[December 7, 2007] Caris Diagnostics has agreed to buy Molecular Profiling Institute for an undisclosed sum, Caris said yesterday. Ref.
